SomaLogic, Twist Bioscience to partner on novel therapeutic antibodies discovery
BOULDER — SomaLogic Inc., a protein-analysis bioscience company that expects to go public via a merger with special purpose acquisition, […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Billionaire plans liquidation of trio of Boulder-based SPACs without merger deals
BOULDER — Special purpose acquisition companies have one, well, special purpose, and that’s to merge with a privately held company…
SomaLogic swaps CEOs amid mounting losses
BOULDER — SomaLogic Inc. (Nasdaq: SLGC) this week elevated a new CEO at the same time the Boulder-based biotechnology company…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
SomaLogic doubles sales, trims losses in third quarter
BOULDER — After a rocky second quarter, SomaLogic Inc. (Nasdaq: SLGC), a Boulder-based biotechnology company that went public last year…